INTEGRA LIFESCIENCES HOLDINGS CORPORATION (NASDAQ:IART) Files An 8-K Submission of Matters to a Vote of Security HoldersItem 5.07. Submission of Matters to a Vote of Security Holders
The Annual Meeting of Stockholders of the Company was held on May 17, 2018. The final results of the matters submitted to a vote of stockholders at the Annual Meeting are as follows:
Item No. 1: All of the Board of Directors’ nominees for director were elected to serve until the Company’s 2019 Annual Meeting or until their respective successors are elected and qualified, by the votes set forth below.
|
Nominees |
For |
Against |
Abstain |
Broker Non-Vote |
|
Peter J. Arduini |
74,756,737 |
245,927 |
11,390 |
1,774,204 |
|
Keith Bradley |
74,444,089 |
559,452 |
10,513 |
1,774,204 |
|
Stuart M. Essig |
74,331,482 |
671,670 |
10,902 |
1,774,204 |
|
Barbara B. Hill |
74,846,282 |
157,728 |
10,044 |
1,774,204 |
|
Lloyd W. Howell, Jr. |
74,942,268 |
61,147 |
10,639 |
1,774,204 |
|
Donald E. Morel, Jr. |
74,946,023 |
57,218 |
10,813 |
1,774,204 |
|
Raymond G. Murphy |
74,732,158 |
270,382 |
11,514 |
1,774,204 |
|
Christian S. Schade |
74,490,242 |
512,568 |
11,244 |
1,774,204 |
|
James M. Sullivan |
74,201,303 |
801,407 |
11,344 |
1,774,204 |
Item No. 2: The stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the 2018 fiscal year, by the votes set forth below.
|
For |
Against |
Abstain |
Broker Non-Vote |
|
75,581,228 |
1,195,476 |
11,554 |
Item No. 3: The stockholders approved, on an advisory, non-binding basis, the compensation of the Company’s named executive officers, by the votes set forth below.
|
For |
Against |
Abstain |
Broker Non-Vote |
|
74,685,343 |
300,826 |
27,885 |
1,774,204 |
About INTEGRA LIFESCIENCES HOLDINGS CORPORATION (NASDAQ:IART)
Integra LifeSciences Holdings Corporation is a medical technology company. The Company focuses on the development, manufacturing and marketing of surgical implants and medical instruments. Its products are used in neurosurgery, extremity reconstruction, orthopedics and general surgery. Its segments include Specialty Surgical Solutions, which offers products, including specialty surgical instrumentation for a range of specialties. Its product category includes products and solutions for dural repair, precision tools and instruments, tissue ablation and neuro critical care, including product portfolios used in neurosurgery operation suites and critical care units, and Orthopedics and Tissue Technologies, which offers products of a combination of differentiated regenerative technology products for soft tissue repair and tissue regeneration products, and small bone fixation and joint replacement hardware products for both upper extremities and lower extremities.